Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,097.08 -19.09 (-0.37%) Dow
38,174.81 -211.28 (-0.55%) Nasdaq
15,918.70 -64.39 (-0.40%) Bitcoin USD
62,955.66 -677.18 (-1.06%) CMC Crypto 200
1,297.08 -41.98 (-3.14%)
GILD Jan 2025 40.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:12PM EDT. Market open.
| Previous close | 0.2200 |
| Open | 0.3300 |
| Bid | 0.0600 |
| Ask | 0.5700 |
| Strike | 40.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.2200 - 0.3300 |
| Contract range | N/A |
| Volume | |
| Open interest | 626 |
ZacksGilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Simply Wall St.Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...
ZacksGilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.
© 2024 Yahoo. All rights reserved.